Latest News about biotech
Recent news which mentions biotech
From Benzinga
MorphoSys Says Novartis Deal Progressing Steadily Despite Safety Concerns Over Bone Marrow Cancer Drug, Pelabresib
April 29, 2024
From Benzinga
From Benzinga
FDA Approves X4 Pharmaceuticals' Mavorixafor As First Therapy For Rare Immunodeficiency Disorder
April 29, 2024
From Benzinga
Johnson & Johnson-Partnered Addex Therapeutics' Epilepsy Candidate Fails Mid-Stage Study, Stock Tanks
April 29, 2024
From Benzinga
mRNA Is Promising A Breakthrough In Fighting Cancer
April 29, 2024
From Benzinga
Double Good News For AstraZeneca's Breast Cancer Drugs
April 29, 2024
From Benzinga
Tickers
INNO
From Business Journals
Kytura Naturals: Canada's Newest Destination for Premium Organic Oils Launches April 27th, 2024
April 26, 2024
From PRLog
COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle
April 26, 2024
From Benzinga
From Benzinga
Sunho Biologics Gets Green Light For Downsized IPO
April 26, 2024
From Benzinga
Ex-Humira Growth Platform Drives AbbVie's Q1 Performance, Drugmaker Lifts Annual Profit Outlook
April 26, 2024
From Benzinga
Five things: Bose spinout HQ, Ty Law's vodka, GE Vernova and sticking stuff to squids
April 26, 2024
From Business Journals
AbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study
April 25, 2024
From Benzinga
What's Going On With Pfizer Stock On Thursday?
April 25, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.